Japan Needs National Efforts to Boost Biosimilar Production: Kameda Chief Pharmacist

Ryohkan Funakoshi, Director, Pharmaceutical Management Department, Kameda Medical Center The Japanese government should promote the domestic manufacturing of biosimilar products as a national strategy, a prominent pharmacist said on January 19 following Daiichi Sankyo’s decision to discontinue its follow-on biologics...read more